Dr. Robert J. Melamede, Ph.D. President & CEO
Dr. Melamede has a Ph.D. in Molecular Biology and Biochemistry from the City University of New York. He retired as Chairman of the Biology Department at University of Colorado, Colorado Springs in 2005, where he continues to teach. Dr. Melamede is recognized as a leading authority on the therapeutic uses of cannabis, and has authored or co-authored dozens of papers on a wide variety of scientific subjects. Dr. Melamede also serves on the Advisory Board of The Journal of the International Association for Cannabis as Medicine, and the Scientific Advisory Board Medical of the Marijuana Policy Advocacy Project, as well as the Scientific Advisory Board of Americans for Safe Access. He also served as a director of Newellink Inc, a Colorado-based company specializing in cancer research.

Richard Cowan Director, Chief Financial Officer
Mr. Cowan has a BA from Yale University in Economics and extensive experience in corporate finance. Prior to his commitment to cannabis activism, Cowan served on the boards of several publicly owned companies, and has extensive experience in corporate finance. Cowan is a former CEO of the National Organization for the Reform of Marijuana Laws, and for the last ten years has published MarijuanaNews.com.

Cannabis Science's corporate leadership team brings together decades of relevant experience and knowledge in the relevant scientific, financial, regulatory and political subjects. If this were all that the management team brought to the table, the company would be well-positioned for success. However, the team also operates on an ethos rooted in the medical cannabis community – a dedication to bringing the safest, most effective medicines possible to the patients who need them.